Engineered transaminase polypeptides for industrial biocatalysis
The present invention provides engineered transaminase polypeptides useful for the synthesis of chiral amine compounds under industrially relevant conditions. The invention also provides polynucleotides encoding the engineered transaminase polypeptides, host cells capable of expressing the engineered transaminases, and methods of using the engineered transaminases for the production of chiral amine compounds.
1. An engineered transaminase comprising a polypeptide sequence having at least 97% sequence identity to SEQ ID NO:4, wherein said engineered transaminase comprises amino acid substitutions in said polypeptide sequence at positions 85 and 422, wherein the amino acid substitution at position 422 is V422C, V422G, or V422A, and the amino acid substitution at position 85 is F85V, wherein the amino acid positions of said polypeptide sequence are numbered with reference to SEQ ID NO:4, and wherein said engineered transaminase exhibits greater enzymatic activity and greater stereoselectivity toward the (S) amine diastereomer than the transaminase of SEQ ID NO:4.
2. The engineered transaminase of claim 1 , wherein said engineered transaminase comprises a polypeptide sequence that has at least 97% sequence identity to the sequence of the transaminase variant set forth in SEQ ID NO: 30.
3. The engineered transaminase of claim 1 , wherein said engineered transaminase comprises a polypeptide sequence of SEQ ID NO: 30.
4. The engineered transaminase of claim 1 , wherein said engineered transaminase comprises at least one improved property compared to wild-type V. fluvialis transaminase.
5. The engineered transaminase of claim 4 , wherein said improved property comprises improved enzymatic activity on a substrate having the following structure:
6. The engineered transaminase of claim 4 , wherein said improved property comprises improved thermostability.
7. The engineered transaminase of claim 1 , wherein said engineered transaminase is purified.
8. A composition comprising the engineered transaminase of claim 1 .